An2 therapeutics to participate in fireside chat at evercore healthconx conference

Menlo park, calif.--(business wire)--an2 therapeutics, inc. (nasdaq: antx), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced that eric easom, co-founder, chairman, president and ceo, will participate in a fireside chat at the 8th annual evercore healthconx conference being held from december 2-4, 2025. details of the event are as follows: eric easom, co-founder, chairman, president and.
EVR Ratings Summary
EVR Quant Ranking